BM
CELL

Brandywine Managers’s PhenomeX Inc. Common Stock CELL Stock Holding History

Brandywine Managers’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29,772
Closed -$29.7K – 44
2023
Q3 		$29.7K Hold
29,772
– – 0.05% 38
2023
Q2 		$14.6K Hold
29,772
– – 0.01% 48
2023
Q1 		$34.5K Hold
29,772
– – 0.02% 48
2022
Q4 		$79.8K Sell
29,772
-25,000
-46% -$65.9K 0.28% 37
2022
Q3 		$157K Hold
54,772
– – 0.52% 38
2022
Q2 		$272K Buy
54,772
+24,096
+79% +$126K 0.67% 34
2022
Q1 		$218K Buy
30,676
+7,584
+33% +$62.7K 0.38% 40
2021
Q4 		$420K Hold
23,092
– – 0.48% 38
2021
Q3 		$452K Buy
23,092
+1,988
+9% +$75.6K 0.47% 37
2021
Q2 		$946K Buy
21,104
+5,001
+31% +$232K 1.08% 22
2021
Q1 		$809K Buy
16,103
+10,684
+197% +$728K 1.08% 23
2020
Q4 		$485K Hold
5,419
– – 0.67% 28
2020
Q3 		$414K Buy
+5,419
New +$344K 0.79% 27

Brandywine Managers's CELL Position: Q4 2023 in Review

Brandywine Managers sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 29,772 shares — an estimated $29.7K sold.

Brandywine Managers first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $946K in Q2 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Brandywine Managers reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Brandywine Managers sold 29,772 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $29.7K.
  • Brandywine Managers first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Brandywine Managers's PhenomeX Inc. Common Stock position peaked at $946K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Brandywine Managers's 13F filing for Q4 2023, filed 14 Feb 2024.